Botulinum Toxin Market by Manufacturers, Regions, Type and Application Forecast to 2030 The Global Botulinum Toxin market study focuses major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure. Browse key industry insights spread across 150 pages with 283 market data tables & 20 figures & charts from the report, “Botulinum Toxin Market Analysis By Product (Botulinum Toxin A, Botulinum Toxin B), Application (Medical, Aesthetic), Gender (Female, Male), Age (13-19, 20-29, 30-39, 40-54, 55 & Above), End-use (Hospitals, Dermatology Clinics, Spas & Cosmetic Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents: https://www.gminsights.com/industry-analysis/botulinum-toxin-market Notably, the high cost of botulinum surgeries and various associated side effects has hampered business growth. However, high focus on improved appearance and the efficacy of Botox in medical treatments in children and adults have positively impacted market progress. For instance, a February 2022 Scandinavian Journal of Gastroenterology study conducted by a group from the Department of Rehabilitation, Chinese Medical University, observed that ultrasound with balloon-guided botulinum toxin injection is effective in cricopharyngeal dysphagia treatment. Moreover, key industry participants have been engaging in growth strategies such as partnerships & collaborations and increasing focus on R&D activities to innovate more products, which has enhanced the product scenario of the botulinum toxin market. For instance, in July 2021, Allergen, an AbbVie company operating in the pharmaceutical sector, announced that the U.S. FDA had approved an extension of its BOTOX label to include eight new muscles for the treatment of upper limb spasticity in adults. The botulinum toxin market has been bifurcated in terms of gender, product, end-use, application, age group, and region. In terms of product, the market has been divided into botulinum toxin B and botulinum toxin A. The botulinum toxin B segment was valued at over $95.3 million in 2021 and is set to grow considerably through the study timeframe. With reference to application, the market has been classified into aesthetic and medical. In 2021, the medical segment reported around $3,453.5 million in revenue and is primed to deliver solid growth up to 2030.
© 2022 All Rights Reserved
www.gminsights.com